According to foreign media reports, Swiss scientists have recently developed a miniature blood laboratory, which is very small and can be implanted under the skin to monitor human health in real time.
It is reported that the device is 14 millimeters long and can be used to update medical staff's health information through the mobile phone in time. According to the research team of the Federal Institute of Technology in Lausanne, Switzerland, this sensor device is very important for patients undergoing chemotherapy. It can prevent key heart attacks by monitoring key chemical components in the blood flow.
The volume of this implant is only a few cubic millimeters, but it has 5 sensors, a wireless transmitter and a power transmission system. This design allows the implant to help physicians monitor high-risk patients anywhere. Outside the human body, a battery pack can provide 0.1 watts of electrical energy through the human skin, so it is only necessary to replace the battery each time without changing the implant, which is convenient to operate.
The advent of this sensor will change the previous treatment of patients. Using this system can continuously and directly monitor the patient's individual tolerance, without the need for age, weight data and weekly blood tests as treatment reference information.
In order to monitor key substances in the body, such as lactate and glucose, the surface of each sensor is covered with enzymes. Basically, this instrument can detect any important information of human body. However, the disadvantage of this design is that all enzyme coatings have a service life. The key to the next optimization is to extend the use time of the enzyme coating on the sensor as much as possible from the design. At present, this enzyme coating can be tested for 1.5 months of continuous use, which is sufficient for many applications.
In addition, the implant is very small and very easy to remove and replace. For patients with chronic diseases, it can send warning messages before symptoms appear and implement effective medical measures. It is expected that within four years, this new implant will be sold commercially. It is not difficult to imagine that after the implant is put into use, it will be easier to monitor patients and facilitate scientific treatment.
Oseltamivir Phosphate (Oseltamivir phosphate) is often referred to as "Tamiflu" (Tamiflu). Produced and sold by the Roche Group, launched in Switzerland in 1999, and launched in China in 2001. It is the most commonly used and one of the most effective drugs against avian influenza, H1N1 influenza virus and influenza B virus. Reducing the incidence of influenza complications can also reduce the use of other medicines, and Tamiflu can increase the survival rate of influenza patients by about 37%.
But it also has large side effects, especially for children. And its price is more expensive to take twice a day, 75mg each time, the retail price of medicines is equivalent to 60 yuan per day, and a course of 5 days is equivalent to about 300 yuan. In addition, taking Tamiflu before the flu has no preventive effect on flu.
Oseltamivir Phosphate,Oseltamivir Phosphate Ingredients,Oseltamivir Phosphate Para Que Sirve,Oseltamivir Phosphate Over The Counter
Jinan Prosperity International Trade Co. Ltd , https://www.jnprosperity.com